Avastin bevacizumab: Phase III started

Genentech began the double-blind Phase III MERiDiAN (GO25632) trial to compare IV Avastin plus paclitaxel vs. placebo plus paclitaxel in about 480 HER2-negative patients with metastatic breast cancer. The trial will also evaluate VEGF-A as a predictive biomarker for efficacy with Avastin. ...